We found that KL-VSHET carriers exhibited a 61% lower likelihood of being diagnosed with aMCI due to AD compared to being cognitively unimpaired and that this association was similar in both APOE ε4 carriers and non-carriers. Here, APOE is linked to Alzheimer disease.